105 related articles for article (PubMed ID: 10608833)
1. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.
Vinion-Dubiel AD; McClain MS; Czajkowsky DM; Iwamoto H; Ye D; Cao P; Schraw W; Szabo G; Blanke SR; Shao Z; Cover TL
J Biol Chem; 1999 Dec; 274(53):37736-42. PubMed ID: 10608833
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes.
Ivie SE; McClain MS; Torres VJ; Algood HM; Lacy DB; Yang R; Blanke SR; Cover TL
Infect Immun; 2008 Jul; 76(7):2843-51. PubMed ID: 18443094
[TBL] [Abstract][Full Text] [Related]
3. Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin.
Pyburn TM; Foegeding NJ; González-Rivera C; McDonald NA; Gould KL; Cover TL; Ohi MD
Mol Microbiol; 2016 Oct; 102(1):22-36. PubMed ID: 27309820
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion.
Sundrud MS; Torres VJ; Unutmaz D; Cover TL
Proc Natl Acad Sci U S A; 2004 May; 101(20):7727-32. PubMed ID: 15128946
[TBL] [Abstract][Full Text] [Related]
5. The intermediate region of Helicobacter pylori VacA is a determinant of toxin potency in a Jurkat T cell assay.
González-Rivera C; Algood HM; Radin JN; McClain MS; Cover TL
Infect Immun; 2012 Aug; 80(8):2578-88. PubMed ID: 22585965
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori supernatants cause epithelial cytoskeletal disruption that is bacterial strain and epithelial cell line dependent but not toxin VacA dependent.
Bebb JR; Letley DP; Rhead JL; Atherton JC
Infect Immun; 2003 Jun; 71(6):3623-7. PubMed ID: 12761150
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori VacA toxin inhibits human immunodeficiency virus infection of primary human T cells.
Oswald-Richter K; Torres VJ; Sundrud MS; VanCompernolle SE; Cover TL; Unutmaz D
J Virol; 2006 Dec; 80(23):11767-75. PubMed ID: 17005643
[TBL] [Abstract][Full Text] [Related]
8. There Are No Insurmountable Barriers: Passage of the
Jarzab M; Skorko-Glonek J
Membranes (Basel); 2023 Dec; 14(1):. PubMed ID: 38248700
[TBL] [Abstract][Full Text] [Related]
9. Structural Analysis of Membrane-associated Forms of Helicobacter pylori VacA Toxin.
Connolly SM; Erwin AL; Sabb M; Hanks JL; Chang L; Torrez RM; Caso GC; Campbell AM; Mosalaganti S; Cover TL; Ohi MD
J Mol Biol; 2024 Feb; 436(4):168432. PubMed ID: 38161000
[TBL] [Abstract][Full Text] [Related]
10. Host cell sensing and restoration of mitochondrial function and metabolism within
Seeger AY; Zaidi F; Alhayek S; Jones RM; Zohair H; Holland RL; Kim I-J; Blanke SR
mBio; 2023 Oct; 14(5):e0211723. PubMed ID: 37815365
[TBL] [Abstract][Full Text] [Related]
11. Treatment with
Reuter S; Raspe J; Uebner H; Contoyannis A; Pastille E; Westendorf AM; Caso GC; Cover TL; Müller A; Taube C
Front Immunol; 2023; 14():1092801. PubMed ID: 36761723
[TBL] [Abstract][Full Text] [Related]
12. Functional Properties of Oligomeric and Monomeric Forms of Helicobacter pylori VacA Toxin.
Caso GC; McClain MS; Erwin AL; Truelock MD; Campbell AM; Leasure CS; Nagel M; Schey KL; Lacy DB; Ohi MD; Cover TL
Infect Immun; 2021 Nov; 89(12):e0034821. PubMed ID: 34543122
[TBL] [Abstract][Full Text] [Related]
13. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants.
Caston RR; Sierra JC; Foegeding NJ; Truelock MD; Campbell AM; Frick-Cheng AE; Bimczok D; Wilson KT; McClain MS; Cover TL
Infect Immun; 2020 May; 88(6):. PubMed ID: 32284370
[No Abstract] [Full Text] [Related]
14. Inhibition of Pore-Forming Proteins.
Omersa N; Podobnik M; Anderluh G
Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546810
[TBL] [Abstract][Full Text] [Related]
15. Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization.
Su M; Erwin AL; Campbell AM; Pyburn TM; Salay LE; Hanks JL; Lacy DB; Akey DL; Cover TL; Ohi MD
J Mol Biol; 2019 May; 431(10):1956-1965. PubMed ID: 30954575
[TBL] [Abstract][Full Text] [Related]
16.
Altobelli A; Bauer M; Velez K; Cover TL; Müller A
mBio; 2019 Mar; 10(2):. PubMed ID: 30890606
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy.
Krueger E; Brown AC
J Biol Eng; 2019; 13():4. PubMed ID: 30820243
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability.
Foegeding NJ; Raghunathan K; Campbell AM; Kim SW; Lau KS; Kenworthy AK; Cover TL; Ohi MD
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30692181
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
